BATS:WDNA WisdomTree BioRevolution Fund (WDNA) Price, Holdings, & News $13.14 -0.12 (-0.91%) Closing price 06/13/2025 02:26 PM EasternExtended Trading$13.16 +0.02 (+0.14%) As of 06/13/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock About WisdomTree BioRevolution Fund (BATS:WDNA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get WDNA alerts:Sign Up Key Stats Today's Range$12.87▼$13.1450-Day Range$11.19▼$13.4652-Week Range$11.20▼$17.22Volume465 shsAverage Volume893 shsMarket Capitalization$1.97 millionAssets Under Management$1.97 millionDividend Yield0.84%Net Expense Ratio0.45%Aggregate RatingModerate Buy ETF OverviewThe WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.Read More… WisdomTree BioRevolution Fund ExpensesTypeWDNATheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.45%0.57%0.57%0.58%0.54%Other Expenses0.00%0.55%0.48%0.43%0.51%Total Expense0.45%0.73%0.72%0.69%0.71%Fee Waiver0.00%-0.69%-0.48%-0.34%-0.54%Net Expense0.45%0.60%0.63%0.65%0.60% Receive WDNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WisdomTree BioRevolution Fund and its competitors with MarketBeat's FREE daily newsletter. Email Address WDNA ETF News HeadlinesWisdomTree BioRevolution Fund (BATS:WDNA) Shares Down 0.9% - What's Next?June 14 at 2:09 AM | americanbankingnews.comWisdomTree Floating Rate Trsy Dgtl N/AMarch 29, 2025 | morningstar.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.June 15, 2025 | Porter & Company (Ad)EPS WisdomTree U.S. LargeCap Fund ETFFebruary 5, 2025 | seekingalpha.comWisdomTree BioRevolution Fund declares annual distribution of $0.1071December 27, 2024 | msn.com2024 Superconvergence BioRevolution Series: A New Therapy For Diabetes?October 16, 2024 | seekingalpha.comSee More Headlines WDNA ETF - Frequently Asked Questions How have WDNA shares performed this year? WisdomTree BioRevolution Fund's stock was trading at $14.3659 on January 1st, 2025. Since then, WDNA stock has decreased by 8.5% and is now trading at $13.1410. View the best growth stocks for 2025 here. Who are WisdomTree BioRevolution Fund's major shareholders? Top institutional investors of WisdomTree BioRevolution Fund include Jane Street Group LLC (7.71%). How do I buy shares of WisdomTree BioRevolution Fund? Shares of WDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of WisdomTree BioRevolution Fund own? Based on aggregate information from My MarketBeat watchlists, some other companies that WisdomTree BioRevolution Fund investors own include NIO (NIO), Insight Select Income Fund (INSI), Merck & Co., Inc. (MRK), iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX), ARK Autonomous Technology & Robotics ETF (ARKQ), ARK Genomic Revolution ETF (ARKG) and Ardelyx (ARDX). Fund Details IssuerWisdomTree Fund NameWisdomTree BioRevolution Fund Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:WDNA Inception Date6/3/2021 Fund ManagerMarlene Walker-Smith, Thomas J. Durante WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkWisdomTree BioRevolution Index CategoryStrategy FocusTheme Development LevelDeveloped Markets RegionGlobal Number of Holdings102 Fund Statistics Assets Under Management$1.97 million Average Daily Volume$0.00 Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorWisdomTree Asset Management, Inc. CustodianState Street Bank and Trust Company DistributorForeside Fund Services, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerFlow Traders Miscellaneous Outstanding Shares150,000Beta1.01 Creation Fee$500.00 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report Top 10 WDNA HoldingsNovozymes A/SHolding Weight: 2.87%Natera (NASDAQ:NTRA)Holding Weight: 2.69%Verve Therapeutics (NASDAQ:VERV)Holding Weight: 2.39%Eli Lilly and Company (NYSE:LLY)Holding Weight: 2.29%REGENXBIO (NASDAQ:RGNX)Holding Weight: 2.15%CRISPR Therapeutics (NASDAQ:CRSP)Holding Weight: 2.10%Agios Pharmaceuticals (NASDAQ:AGIO)Holding Weight: 2.06%Gilead Sciences (NASDAQ:GILD)Holding Weight: 2.04%Intellia Therapeutics (NASDAQ:NTLA)Holding Weight: 2.00%Twist Bioscience (NASDAQ:TWST)Holding Weight: 1.96%Full Holdings DetailsWDNA Sector ExposureWDNA Industry Exposure This page (BATS:WDNA) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.